文献速递产科母胎医学

双胎妊娠11-13周颈项透明层增厚与结局

Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-02-13

该回顾性分析纳入2002至2019年间6225例双胎妊娠,评估11-13周NT≥95百分位对不良结局的预测价值。在无重大畸形的单绒毛膜双羊膜囊(MCDA)双胎中,NT≥95百分位与20周前胎儿丢失或需内镜激光手术风险显著升高相关(23.5% vs 9.8%,P<0.0001),但筛查性能较差(检出率23.5%,假阳性率8.9%)。在双绒毛膜(DC)双胎中,高NT与不良结局无显著差异。

要点

  • MCDA双胎中NT≥95百分位者20周前胎儿丢失或激光手术风险显著高于NT正常者(23.5% vs 9.8%)。
  • MCDA双胎中NT≥95百分位预测20周前不良结局的检出率仅23.5%,假阳性率8.9%,筛查性能差。
  • DC双胎中高NT与不良结局无显著差异;MCMA双胎病例数过少无法评估。

核心结论

  • 在无重大胎儿异常的MCDA双胎中,11-13周NT测量是不良妊娠结局的差筛查试验。
  • 但NT≥95百分位(尤其≥99百分位)与20周前胎儿丢失或需内镜激光手术风险显著增加相关。
  • 加强监测和早期干预能否减少这些并发症尚待确定。

研究设计与样本

  • 回顾性分析2002至2019年前瞻性收集的双胎妊娠11-13周常规超声检查数据。
  • 研究人群为6225例双胎妊娠,包括4896例(78.7%)DC、1274例(20.5%)MCDA和55例(0.9%)MCMA。
  • 纳入无重大缺陷或染色体异常的妊娠,评估NT≥95百分位(一个或两个胎儿)对不良结局的预测价值。

主要发现

  • DC双胎中NT≥95百分位发生率为8.3%;MCDA双胎为10.4%,显著高于DC(P=0.016);MCMA双胎为9.1%,与DC无显著差异(P=0.804)。
  • DC双胎中高NT发生率在双存活与不良结局组间无显著差异。
  • MCDA双胎中,至少一胎20周前死亡或需内镜激光手术者NT≥95百分位发生率显著高于双存活者(23.5% vs 9.8%,P<0.0001)。
  • MCDA双胎Kaplan-Meier分析显示NT≥95百分位者20周前生存率显著低于NT<95百分位者(P=0.001),≥20周生存率无显著差异(P=0.960)。
  • MCDA双胎中NT≥95百分位预测20周前胎儿丢失或需激光手术的检出率23.5%、假阳性率8.9%,相对风险2.640(95%CI 1.854-3.758;P<0.0001)。

关键数值与推荐

  • MCDA双胎20周前胎儿丢失或需激光手术总体发生率为10.7%。
  • NT≥95百分位亚组(占总10.4%)该发生率升至24.1%;NT≥99百分位亚组(占总3.3%)升至40.5%。

临床怎么用

  • MCDA双胎11-13周NT≥95百分位(尤其≥99百分位)可识别20周前胎儿丢失或需激光手术风险较高的亚组。
  • NT作为筛查试验性能差,检出率低,需结合其他监测手段。
  • 对高危组加强监测和早期干预能否减少并发症尚待确定。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the value of increased fetal nuchal translucency thickness (NT) at the 11-13-week scan in the prediction of adverse outcome in dichorionic (DC), monochorionic diamniotic (MCDA) and monochorionic monoamniotic (MCMA) twin pregnancies. METHODS: This was a retrospective analysis of prospectively collected data on twin pregnancies undergoing routine ultrasound examination at 11-13 weeks' gestation between 2002 and 2019. In pregnancies with no major defects or chromosomal abnormalities, we examined the value of increased NT ≥ 95th percentile in one or both fetuses in the prediction of, first, miscarriage or death of one or both fetuses at < 20 and < 24 weeks' gestation in DC, MCDA and MCMA twin pregnancies, second, death of one or both fetuses or neonates at ≥ 24 weeks in DC, MCDA and MCMA twin pregnancies, third, development of twin-twin transfusion syndrome (TTTS) or selective fetal growth restriction (sFGR) treated by endoscopic laser surgery at < 20 and ≥ 20 weeks' gestation in MCDA pregnancies, and, fourth, either fetal loss or laser surgery at < 20 weeks' gestation in MCDA pregnancies. RESULTS: The study population of 6225 twin pregnancies included 4896 (78.7%) DC, 1274 (20.5%) MCDA and 55 (0.9%) MCMA pregnancies. The incidence of NT ≥ 95th percentile in one or both fetuses in DC twin pregnancies was 8.3%; in MCDA twins the incidence was significantly higher (10.4%; P = 0.016), but in MCMA twins it was not significantly different (9.1%; P = 0.804) from that in DC twins. In DC twin pregnancies, the incidence of high NT was not significantly different between those with two survivors and those with adverse outcome. In MCMA twin pregnancies, the number of cases was too small for meaningful assessment of the relationship between high NT and adverse outcome. In MCDA twin pregnancies with at least one fetal death or need for endoscopic laser surgery at < 20 weeks' gestation, the incidence of NT ≥ 95th percentile was significantly higher than in those with two survivors (23.5% vs 9.8%; P < 0.0001). Kaplan-Meier analysis in MCDA twin pregnancies showed that, in those with NT ≥ 95th percentile, there was significantly lower survival at < 20 weeks' gestation than in those with NT < 95th percentile (P = 0.001); this was not the case for survival at ≥ 20 weeks (P = 0.960). The performance of screening by fetal NT ≥ 95th percentile for prediction of either fetal loss or need for endoscopic laser surgery at < 20 weeks' gestation was poor, with a detection rate of 23.5% at a false-positive rate of 8.9%, and the relative risk, in comparison to fetal NT < 95th percentile, was 2.640 (95% CI, 1.854-3.758; P < 0.0001). In MCDA twin pregnancies, the overall rate of fetal loss or need for laser surgery at < 20 weeks' gestation was 10.7% but, in the subgroups with NT ≥ 95th and NT ≥ 99th percentiles, which constituted 10.4% and 3.3% of the total, the rates increased to 24.1% and 40.5%, respectively. CONCLUSIONS: In MCDA twin pregnancies with no major fetal abnormalities, measurement of NT at the 11-13-week scan is a poor screening test for adverse pregnancy outcome. However, the finding in one or both fetuses of NT ≥ 95th percentile, and more so ≥ 99th percentile, is associated with a substantially increased risk of fetal loss or need for endoscopic laser surgery at < 20 weeks' gestation. The extent to which closer monitoring and earlier intervention in the high-risk group can reduce these complications remains to be determined. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cimpoca B, Syngelaki A, Litwinska E, et al. Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy. Ultrasound Obstet Gynecol. 2020. PMID: 31773823. doi:10.1002/uog.21935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。